{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T07:41:40Z","timestamp":1794037300047,"version":"4.8.0"},"reference-count":320,"publisher":"Elsevier BV","issue":"2","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/j.pharmthera.2013.12.009","type":"journal-article","created":{"date-parts":[[2013,12,20]],"date-time":"2013-12-20T13:09:50Z","timestamp":1387544990000},"page":"244-257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":234,"title":["Genetic mouse models of brain ageing and Alzheimer's disease"],"prefix":"10.1016","volume":"142","author":[{"given":"Andras","family":"Bilkei-Gorzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2013.12.009_bb0005","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.2174\/138161210793176572","article-title":"Neuroinflammation, oxidative stress and the pathogenesis of Alzheimer's disease","volume":"16","author":"Agostinho","year":"2010","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0010","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/jnr.22172","article-title":"Memantine lowers amyloid-beta peptide levels in neuronal cultures and in APP\/PS1 transgenic mice","volume":"88","author":"Alley","year":"2010","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0015","doi-asserted-by":"crossref","first-page":"7915","DOI":"10.1073\/pnas.90.17.7915","article-title":"Oxidants, antioxidants, and the degenerative diseases of aging","volume":"90","author":"Ames","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0020","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.nbd.2012.03.009","article-title":"Effects of a tacrine-8-hydroxyquinoline hybrid (IQM-622) on Abeta accumulation and cell death: involvement in hippocampal neuronal loss in Alzheimer's disease","volume":"46","author":"Antequera","year":"2012","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0025","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0006-8993(02)03262-6","article-title":"Impairment of cholinergic neurotransmission in adult and aged transgenic Tg2576 mouse brain expressing the Swedish mutation of human beta-amyloid precursor protein","volume":"953","author":"Apelt","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0030","doi-asserted-by":"crossref","first-page":"e17397","DOI":"10.1371\/journal.pone.0017397","article-title":"DHA improves cognition and prevents dysfunction of entorhinal cortex neurons in 3xTg-AD mice","volume":"6","author":"Arsenault","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0035","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.neuron.2010.04.031","article-title":"Probing the biology of Alzheimer's disease in mice","volume":"66","author":"Ashe","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0040","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.clinph.2009.02.005","article-title":"Ibuprofen treatment modifies cortical sources of EEG rhythms in mild Alzheimer's disease","volume":"120","author":"Babiloni","year":"2009","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0045","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/bmj.38369.459988.8F","article-title":"Quetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trial","volume":"330","author":"Ballard","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0050","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.tins.2004.07.005","article-title":"Free radicals and aging","volume":"27","author":"Barja","year":"2004","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0055","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.bbr.2004.06.014","article-title":"Impaired Pavlovian cued fear conditioning in Tg2576 mice expressing a human mutant amyloid precursor protein gene","volume":"157","author":"Barnes","year":"2005","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0060","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1474-9726.2008.00387.x","article-title":"Impact of reduced insulin-like growth factor-1\/insulin signaling on aging in mammals: novel findings","volume":"7","author":"Bartke","year":"2008","journal-title":"Aging Cell"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0065","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1523\/JNEUROSCI.4936-10.2011","article-title":"Noninvasive magnetic resonance imaging detection of cerebral amyloid angiopathy-related microvascular alterations using superparamagnetic iron oxide particles in APP transgenic mouse models of Alzheimer's disease: application to passive Abeta immunotherapy","volume":"31","author":"Beckmann","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0070","doi-asserted-by":"crossref","first-page":"8453","DOI":"10.1523\/JNEUROSCI.23-24-08453.2003","article-title":"Age-dependent cerebrovascular abnormalities and blood flow disturbances in APP23 mice modeling Alzheimer's disease","volume":"23","author":"Beckmann","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0075","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0197-4580(99)00065-2","article-title":"Evidence for glial-mediated inflammation in aged APP(SW) transgenic mice","volume":"20","author":"Benzing","year":"1999","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0080","doi-asserted-by":"crossref","first-page":"4334","DOI":"10.1523\/JNEUROSCI.5845-11.2012","article-title":"Bidirectional relationship between functional connectivity and amyloid-beta deposition in mouse brain","volume":"32","author":"Bero","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0085","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0278-6915(93)90191-Z","article-title":"Neurotoxic effect of enteral aluminium","volume":"31","author":"Bilkei-Gorzo","year":"1993","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0090","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1098\/rstb.2011.0388","article-title":"The endocannabinoid system in normal and pathological brain ageing","volume":"367","author":"Bilkei-Gorzo","year":"2012","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0095","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1523\/JNEUROSCI.4800-06.2007","article-title":"Learning decreases A beta*56 and tau pathology and ameliorates behavioral decline in 3xTg-AD mice","volume":"27","author":"Billings","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0100","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.neuron.2005.01.040","article-title":"Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice","volume":"45","author":"Billings","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0105","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000330363","article-title":"Inhibition of microglial activation protects hippocampal neurogenesis and improves cognitive deficits in a transgenic mouse model for Alzheimer's disease","volume":"9","author":"Biscaro","year":"2012","journal-title":"Neurodegener Dis"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0110","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/nature08983","article-title":"Neural mechanisms of ageing and cognitive decline","volume":"464","author":"Bishop","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0115","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1001\/archneurol.2012.90","article-title":"Effect of immunotherapy with bapineuzumab on cerebrospinal fluid biomarker levels in patients with mild to moderate Alzheimer disease","volume":"69","author":"Blennow","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0120","doi-asserted-by":"crossref","first-page":"13594","DOI":"10.1073\/pnas.0901402106","article-title":"Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease","volume":"106","author":"Blurton-Jones","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0125","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1523\/JNEUROSCI.22-08-03234.2002","article-title":"Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis","volume":"22","author":"Boncristiano","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0130","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1523\/JNEUROSCI.22-02-00515.2002","article-title":"Amyloid-associated neuron loss and gliogenesis in the neocortex of amyloid precursor protein transgenic mice","volume":"22","author":"Bondolfi","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0135","doi-asserted-by":"crossref","first-page":"12543","DOI":"10.1523\/JNEUROSCI.1589-11.2011","article-title":"Accelerated age-related cognitive decline and neurodegeneration, caused by deficient DNA repair","volume":"31","author":"Borgesius","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0140","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1749-6632.2000.tb06653.x","article-title":"Transgenic mouse models of Alzheimer's disease","volume":"908","author":"Bornemann","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0145","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1080\/07853890802186905","article-title":"Molecular genetics of Alzheimer's disease: an update","volume":"40","author":"Brouwers","year":"2008","journal-title":"Ann Med"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0150","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1523\/JNEUROSCI.5599-03.2004","article-title":"Induction of brain-derived neurotrophic factor in plaque-associated glial cells of aged APP23 transgenic mice","volume":"24","author":"Burbach","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0155","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1073\/pnas.94.2.674","article-title":"Free radical oxidation of brain proteins in accelerated senescence and its modulation by N-tert-butyl-alpha-phenylnitrone","volume":"94","author":"Butterfield","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0160","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1073\/pnas.0712197105","article-title":"Transthyretin protects Alzheimer's mice from the behavioral and biochemical effects of Abeta toxicity","volume":"105","author":"Buxbaum","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0165","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.neuron.2006.01.020","article-title":"M1 receptors play a central role in modulating AD-like pathology in transgenic mice","volume":"49","author":"Caccamo","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0170","doi-asserted-by":"crossref","first-page":"14088","DOI":"10.1073\/pnas.96.24.14088","article-title":"Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid","volume":"96","author":"Calhoun","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0175","doi-asserted-by":"crossref","first-page":"14436","DOI":"10.1523\/JNEUROSCI.3836-11.2011","article-title":"Chronic stress exacerbates tau pathology, neurodegeneration, and cognitive performance through a corticotropin-releasing factor receptor-dependent mechanism in a transgenic mouse model of tauopathy","volume":"31","author":"Carroll","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0180","doi-asserted-by":"crossref","first-page":"13357","DOI":"10.1523\/JNEUROSCI.2718-07.2007","article-title":"Progesterone and estrogen regulate Alzheimer-like neuropathology in female 3xTg-AD mice","volume":"27","author":"Carroll","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0185","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0896-6273(93)90173-O","article-title":"Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice","volume":"10","author":"Carson","year":"1993","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0190","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1212\/WNL.0b013e3181a2e8f6","article-title":"Altered anandamide degradation in attention-deficit\/hyperactivity disorder","volume":"72","author":"Centonze","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0195","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3233\/JAD-122143","article-title":"Early endosomal abnormalities and cholinergic neuron degeneration in amyloid-beta protein precursor transgenic mice","volume":"34","author":"Choi","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0200","first-page":"182","article-title":"Effects of age and dietary restriction on lifespan and oxidative stress of SAMP8 mice with learning and memory impairments","volume":"4","author":"Choi","year":"2000","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0205","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.neurobiolaging.2010.07.008","article-title":"Pro-oxidant diet enhances beta\/gamma secretase-mediated APP processing in APP\/PS1 transgenic mice","volume":"33","author":"Choudhry","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0210","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1523\/JNEUROSCI.21-03-00858.2001","article-title":"Growth arrest of individual senile plaques in a model of Alzheimer's disease observed by in vivo multiphoton microscopy","volume":"21","author":"Christie","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0215","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/j.cellsig.2012.05.008","article-title":"Alzheimer culprits: cellular crossroads and interplay","volume":"24","author":"Claeysen","year":"2012","journal-title":"Cell Signal"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0220","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1101\/lm.51002","article-title":"Overexpression of hAPPswe impairs rewarded alternation and contextual fear conditioning in a transgenic mouse model of Alzheimer's disease","volume":"9","author":"Corcoran","year":"2002","journal-title":"Learn Mem"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0225","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3109\/07853899809002605","article-title":"Molecular genetics of Alzheimer's disease","volume":"30","author":"Cruts","year":"1998","journal-title":"Ann Med"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0230","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0197-4580(95)02060-8","article-title":"The canine as an animal model of human aging and dementia","volume":"17","author":"Cummings","year":"1996","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0235","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/dneu.22028","article-title":"Neurogenesis and progenitor cells in the adult human brain: a comparison between hippocampal and subventricular progenitor proliferation","volume":"72","author":"Curtis","year":"2012","journal-title":"Dev Neurobiol"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0240","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/nn.2709","article-title":"Caspase-3 triggers early synaptic dysfunction in a mouse model of Alzheimer's disease","volume":"14","author":"D'Amelio","year":"2011","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0245","doi-asserted-by":"crossref","first-page":"681","DOI":"10.3233\/JAD-2012-121543","article-title":"Episodic-like memory for what\u2013where\u2013which occasion is selectively impaired in the 3xTgAD mouse model of Alzheimer's disease","volume":"33","author":"Davis","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0250","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.neurobiolaging.2005.04.011","article-title":"In vivo MRI and histological evaluation of brain atrophy in APP\/PS1 transgenic mice","volume":"27","author":"Delatour","year":"2006","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0255","first-page":"27","article-title":"Treatment of Alzheimer's disease with stabilized oral nicotinamide adenine dinucleotide: a randomized, double-blind study","volume":"30","author":"Demarin","year":"2004","journal-title":"Drugs Exp Clin Res"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0260","doi-asserted-by":"crossref","first-page":"16725a","DOI":"10.1523\/JNEUROSCI.2153-12.2012","article-title":"Cognitive enhancement with rosiglitazone links the hippocampal PPARgamma and ERK MAPK signaling pathways","volume":"32","author":"Denner","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0265","doi-asserted-by":"crossref","first-page":"e32792","DOI":"10.1371\/journal.pone.0032792","article-title":"Mechanisms underlying insulin deficiency-induced acceleration of beta-amyloidosis in a mouse model of Alzheimer's disease","volume":"7","author":"Devi","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0270","doi-asserted-by":"crossref","first-page":"e12974","DOI":"10.1371\/journal.pone.0012974","article-title":"Phospho-eIF2alpha level is important for determining abilities of BACE1 reduction to rescue cholinergic neurodegeneration and memory defects in 5XFAD mice","volume":"5","author":"Devi","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0275","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.nbd.2003.08.003","article-title":"Neuropeptide alterations in the hippocampal formation and cortex of transgenic mice overexpressing beta-amyloid precursor protein (APP) with the Swedish double mutation (APP23)","volume":"14","author":"Diez","year":"2003","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0280","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jneuroim.2006.10.003","article-title":"SOD1 overexpression alters ROS production and reduces neurotoxic inflammatory signaling in microglial cells","volume":"182","author":"Dimayuga","year":"2007","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0285","doi-asserted-by":"crossref","first-page":"11622","DOI":"10.1523\/JNEUROSCI.3153-08.2008","article-title":"Retinoic acid attenuates beta-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model","volume":"28","author":"Ding","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0290","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00213-005-2230-6","article-title":"Acetylcholinesterase inhibitors ameliorate behavioral deficits in the Tg2576 mouse model of Alzheimer's disease","volume":"181","author":"Dong","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0295","doi-asserted-by":"crossref","first-page":"12926","DOI":"10.1073\/pnas.0903200106","article-title":"Induction of cerebral beta-amyloidosis: intracerebral versus systemic Abeta inoculation","volume":"106","author":"Eisele","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0300","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/nm1555","article-title":"Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease","volume":"13","author":"El Khoury","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0305","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/sj.onc.1208207","article-title":"CuZnSOD deficiency leads to persistent and widespread oxidative damage and hepatocarcinogenesis later in life","volume":"24","author":"Elchuri","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0310","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ejphar.2009.10.020","article-title":"Searching for new animal models of Alzheimer's disease","volume":"626","author":"Epis","year":"2010","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0315","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S0891-5849(00)00161-1","article-title":"Mitochondrial oxidative stress in mice lacking the glutathione peroxidase-1 gene","volume":"28","author":"Esposito","year":"2000","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0320","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jalz.2011.09.224","article-title":"Safety and biomarker effects of solanezumab in patients with Alzheimer's disease","volume":"8","author":"Farlow","year":"2012","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0325","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1016\/j.lfs.2004.05.026","article-title":"DHEAS improves learning and memory in aged SAMP8 mice but not in diabetic mice","volume":"75","author":"Farr","year":"2004","journal-title":"Life Sci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0330","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1046\/j.1471-4159.2003.01580.x","article-title":"The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and brain oxidative stress in aged SAMP8 mice","volume":"84","author":"Farr","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0335","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.bbr.2012.12.055","article-title":"Longitudinal behavioral changes in the APP\/PS1 transgenic Alzheimer's disease model","volume":"242C","author":"Ferguson","year":"2013","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0340","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/35041687","article-title":"Oxidants, oxidative stress and the biology of ageing","volume":"408","author":"Finkel","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0345","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.neurobiolaging.2008.06.009","article-title":"Long-term proteasome dysfunction in the mouse brain by expression of aberrant ubiquitin","volume":"30","author":"Fischer","year":"2009","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0350","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/j.freeradbiomed.2009.08.016","article-title":"Radiation-induced reductions in neurogenesis are ameliorated in mice deficient in CuZnSOD or MnSOD","volume":"47","author":"Fishman","year":"2009","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0149-7634(96)00063-2","article-title":"Learning and memory in the SAMP8 mouse","volume":"22","author":"Flood","year":"1998","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0360","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/0031-9384(95)00125-3","article-title":"Age-related changes in learning, memory, and lipofuscin as a function of the percentage of SAMP8 genes","volume":"58","author":"Flood","year":"1995","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0365","doi-asserted-by":"crossref","first-page":"6457","DOI":"10.1523\/JNEUROSCI.0901-04.2004","article-title":"Absence of C1q leads to less neuropathology in transgenic mouse models of Alzheimer's disease","volume":"24","author":"Fonseca","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0370","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S1474-4422(07)70179-5","article-title":"A new framework for the diagnosis of Alzheimer's disease","volume":"6","author":"Foster","year":"2007","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0375","first-page":"307","article-title":"Microglial response to amyloid plaques in APPsw transgenic mice","volume":"152","author":"Frautschy","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0380","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/ana.21340","article-title":"A nasal proteosome adjuvant activates microglia and prevents amyloid deposition","volume":"63","author":"Frenkel","year":"2008","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0385","doi-asserted-by":"crossref","first-page":"11157","DOI":"10.1523\/JNEUROSCI.2884-10.2010","article-title":"A noncompetitive BACE1 inhibitor TAK-070 ameliorates Abeta pathology and behavioral deficits in a mouse model of Alzheimer's disease","volume":"30","author":"Fukumoto","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0390","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1046\/j.1460-9568.1998.00058.x","article-title":"Reversible impairment of long-term potentiation in transgenic Cu\/Zn-SOD mice","volume":"10","author":"Gahtan","year":"1998","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0395","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1001\/archneurol.2012.85","article-title":"Antioxidants for Alzheimer disease: a randomized clinical trial with cerebrospinal fluid biomarker measures","volume":"69","author":"Galasko","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0400","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3233\/JAD-2011-101635","article-title":"Physical exercise protects against Alzheimer's disease in 3xTg-AD mice","volume":"24","author":"Garcia-Mesa","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0405","series-title":"Oxidative stress and the aging brain: from theory to prevention","first-page":"353","author":"Gemma","year":"2007"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0410","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/ana.410320510","article-title":"Disease-specific patterns of locus coeruleus cell loss","volume":"32","author":"German","year":"1992","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0415","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1212\/01.WNL.0000159740.16984.3C","article-title":"Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial","volume":"64","author":"Gilman","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0420","series-title":"Brain aging models methods, and mechanisms","first-page":"159","article-title":"Expression profile analysis of brain aging","author":"Ginsberg","year":"2007"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0425","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3233\/JAD-2012-100732","article-title":"Early increases in soluble amyloid-beta levels coincide with cholinergic degeneration in 3xTg-AD mice","volume":"32","author":"Girao da Cruz","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0430","doi-asserted-by":"crossref","first-page":"781","DOI":"10.3233\/JAD-2012-120982","article-title":"Evidence for early cognitive impairment related to frontal cortex in the 5XFAD mouse model of Alzheimer's disease","volume":"33","author":"Girard","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0435","series-title":"Brain aging models, methods, and mechanisms","article-title":"Changes in cognitive function in human aging","author":"Glisky","year":"2007"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0440","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000318845","article-title":"Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III study","volume":"30","author":"Gold","year":"2010","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0445","doi-asserted-by":"crossref","first-page":"11500","DOI":"10.1523\/JNEUROSCI.3203-08.2008","article-title":"Nicotinamide restores cognition in Alzheimer's disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau","volume":"28","author":"Green","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0450","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.neurobiolaging.2007.05.020","article-title":"Early locus coeruleus degeneration and olfactory dysfunctions in Tg2576 mice","volume":"30","author":"Guerin","year":"2009","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0455","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.neurobiolaging.2012.05.009","article-title":"Intranasal deferoxamine reverses iron-induced memory deficits and inhibits amyloidogenic APP processing in a transgenic mouse model of Alzheimer's disease","volume":"34","author":"Guo","year":"2013","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0460","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1101\/lm.026070.112","article-title":"Restoration of dopamine release deficits during object recognition memory acquisition attenuates cognitive impairment in a triple transgenic mice model of Alzheimer's disease","volume":"19","author":"Guzman-Ramos","year":"2012","journal-title":"Learn Mem"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0465","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.brainres.2012.02.015","article-title":"The effect of ageing on neurogenesis and oxidative stress in the APP(swe)\/PS1(deltaE9) mouse model of Alzheimer's disease","volume":"1449","author":"Hamilton","year":"2012","journal-title":"Brain Res"},{"issue":"5","key":"10.1016\/j.pharmthera.2013.12.009_bb0470","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.biopsych.2012.06.013","article-title":"Selective loss of noradrenaline exacerbates early cognitive dysfunction and synaptic deficits in APP\/PS1 mice","volume":"73","author":"Hammerschmidt","year":"2012","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0475","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.biopsych.2012.06.013","article-title":"Selective loss of noradrenaline exacerbates early cognitive dysfunction and synaptic deficits in APP\/PS1 mice","volume":"73","author":"Hammerschmidt","year":"2013","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0480","doi-asserted-by":"crossref","first-page":"13542","DOI":"10.1523\/JNEUROSCI.4686-08.2008","article-title":"Cerebrovascular dysfunction in amyloid precursor protein transgenic mice: contribution of soluble and insoluble amyloid-beta peptide, partial restoration via gamma-secretase inhibition","volume":"28","author":"Han","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0485","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/geronj\/11.3.298","article-title":"Aging: a theory based on free radical and radiation chemistry","volume":"11","author":"Harman","year":"1956","journal-title":"J Gerontol"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0490","doi-asserted-by":"crossref","first-page":"592","DOI":"10.2174\/156720511796391935","article-title":"Rosiglitazone does not improve cognition or global function when used as adjunctive therapy to AChE inhibitors in mild-to-moderate Alzheimer's disease: two phase 3 studies","volume":"8","author":"Harrington","year":"2011","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0495","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2353\/ajpath.2008.070730","article-title":"Retinal dysfunction and progressive retinal cell death in SOD1-deficient mice","volume":"172","author":"Hashizume","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0500","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1126\/science.1079161","article-title":"Aging and genome maintenance: lessons from the mouse?","volume":"299","author":"Hasty","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0505","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1096\/fj.00-0528fje","article-title":"Reduction of Abeta accumulation in the Tg2576 animal model of Alzheimer's disease after oral administration of the phosphatidyl-inositol kinase inhibitor wortmannin","volume":"15","author":"Haugabook","year":"2001","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0510","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1007\/s11064-008-9808-4","article-title":"Oxidative damage and cognitive dysfunction: antioxidant treatments to promote healthy brain aging","volume":"34","author":"Head","year":"2009","journal-title":"Neurochem Res"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0515","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1101\/lm.2606","article-title":"Spatial navigation in complex and radial mazes in APP23 animals and neurotrophin signaling as a biological marker of early impairment","volume":"13","author":"Hellweg","year":"2006","journal-title":"Learn Mem"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0520","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1523\/JNEUROSCI.4236-05.2006","article-title":"Locus ceruleus degeneration promotes Alzheimer pathogenesis in amyloid precursor protein 23 transgenic mice","volume":"26","author":"Heneka","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0525","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3233\/JAD-2010-1414","article-title":"Neuroinflammation in Alzheimer's disease: mechanisms, pathologic consequences, and potential for therapeutic manipulation","volume":"21","author":"Hensley","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0530","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2174\/156720509787602906","article-title":"Visualization of brain amyloid and microglial activation in mouse models of Alzheimer's disease","volume":"6","author":"Higuchi","year":"2009","journal-title":"Curr Alzheimer Res"},{"issue":"833","key":"10.1016\/j.pharmthera.2013.12.009_bb0535","first-page":"e839","article-title":"No improvement after chronic ibuprofen treatment in the 5XFAD mouse model of Alzheimer's disease","volume":"33","author":"Hillmann","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0540","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.exger.2004.08.017","article-title":"IGF-1 signaling and aging","volume":"39","author":"Holzenberger","year":"2004","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0545","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1523\/JNEUROSCI.5209-10.2011","article-title":"PKC epsilon activation prevents synaptic loss, Abeta elevation, and cognitive deficits in Alzheimer's disease transgenic mice","volume":"31","author":"Hongpaisan","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0550","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.brainres.2007.08.063","article-title":"Amyloid beta deposition is related to decreased glucose transporter-1 levels and hippocampal atrophy in brains of aged APP\/PS1 mice","volume":"1181","author":"Hooijmans","year":"2007","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0555","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.nbd.2008.12.002","article-title":"DHA and cholesterol containing diets influence Alzheimer-like pathology, cognition and cerebral vasculature in APPswe\/PS1dE9 mice","volume":"33","author":"Hooijmans","year":"2009","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0560","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.274.5284.99","article-title":"Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice","volume":"274","author":"Hsiao","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0565","doi-asserted-by":"crossref","first-page":"3933","DOI":"10.1523\/JNEUROSCI.5566-05.2006","article-title":"Aging-dependent alterations in synaptic plasticity and memory in mice that overexpress extracellular superoxide dismutase","volume":"26","author":"Hu","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0570","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/gps.2314","article-title":"Working memory in early Alzheimer's disease: a neuropsychological review","volume":"25","author":"Huntley","year":"2010","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0580","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1101\/lm.2111311","article-title":"Insulin receptor substrate 2 is a negative regulator of memory formation","volume":"18","author":"Irvine","year":"2011","journal-title":"Learn Mem"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0585","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1212\/WNL.0b013e31820e7b25","article-title":"POLG1 manifestations in childhood","volume":"76","author":"Isohanni","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0590","doi-asserted-by":"crossref","first-page":"5161","DOI":"10.1073\/pnas.0600948103","article-title":"Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease","volume":"103","author":"Jacobsen","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0595","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.neuron.2013.01.002","article-title":"Vulnerable neural systems and the borderland of brain aging and neurodegeneration","volume":"77","author":"Jagust","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0600","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.neuint.2010.02.001","article-title":"Induced LC degeneration in APP\/PS1 transgenic mice accelerates early cerebral amyloidosis and cognitive deficits","volume":"57","author":"Jardanhazi-Kurutz","year":"2010","journal-title":"Neurochem Int"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0605","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.neuroscience.2010.11.052","article-title":"Distinct adrenergic system changes and neuroinflammation in response to induced locus ceruleus degeneration in APP\/PS1 transgenic mice","volume":"176","author":"Jardanhazi-Kurutz","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0610","first-page":"CD006378","article-title":"Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease","volume":"2","author":"Jaturapatporn","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"196","key":"10.1016\/j.pharmthera.2013.12.009_bb0615","first-page":"e129","article-title":"Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Abeta aggregation in the 5XFAD mouse model of Alzheimer's disease","volume":"33","author":"Jawhar","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0620","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.neurobiolaging.2008.08.022","article-title":"High-fat diet aggravates amyloid-beta and tau pathologies in the 3xTg-AD mouse model","volume":"31","author":"Julien","year":"2010","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0625","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.neurobiolaging.2011.04.012","article-title":"The noradrenaline precursor L-DOPS reduces pathology in a mouse model of Alzheimer's disease","volume":"33","author":"Kalinin","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0630","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.bbr.2011.12.021","article-title":"Cognitive phenotyping of amyloid precursor protein transgenic J20 mice","volume":"228","author":"Karl","year":"2012","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0635","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.mri.2013.06.013","article-title":"Neurofibrillary tangles and plaques are not accompanied by white matter pathology in aged triple transgenic-Alzheimer disease mice","volume":"31","author":"Kastyak-Ibrahim","year":"2013","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0640","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.neurobiolaging.2012.09.010","article-title":"Prazosin, an alpha(1)-adrenoceptor antagonist, prevents memory deterioration in the APP23 transgenic mouse model of Alzheimer's disease","volume":"34","author":"Katsouri","year":"2013","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0645","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3233\/JAD-2011-110417","article-title":"Long-term effects of galantamine on cognitive function in Alzheimer's disease: a large-scale international retrospective study","volume":"27","author":"Kavanagh","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0650","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0531-5565(96)00063-0","article-title":"Neuropathological studies on strains of senescence-accelerated mice (SAM) with age-related deficits in learning and memory","volume":"32","author":"Kawamata","year":"1997","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0655","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1161\/01.STR.30.9.1962","article-title":"Exacerbation of delayed cell injury after transient global ischemia in mutant mice with CuZn superoxide dismutase deficiency","volume":"30","author":"Kawase","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0660","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0197-4580(02)00098-2","article-title":"Progressive age-related impairment of cognitive behavior in APP23 transgenic mice","volume":"24","author":"Kelly","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0665","first-page":"233","article-title":"Effects of age and dietary restriction on animal model SAMP8 mice with learning and memory impairments","volume":"4","author":"Kim","year":"2000","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0670","doi-asserted-by":"crossref","first-page":"4387","DOI":"10.1523\/JNEUROSCI.4165-12.2013","article-title":"Deletion of Abca7 increases cerebral amyloid-beta accumulation in the J20 mouse model of Alzheimer's disease","volume":"33","author":"Kim","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0675","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1471-4159.2010.06608.x","article-title":"Partial reduction of BACE1 improves synaptic plasticity, recent and remote memories in Alzheimer's disease transgenic mice","volume":"113","author":"Kimura","year":"2010","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0680","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nature04723","article-title":"Loss of autophagy in the central nervous system causes neurodegeneration in mice","volume":"441","author":"Komatsu","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0685","doi-asserted-by":"crossref","first-page":"6331","DOI":"10.1523\/JNEUROSCI.22-15-06331.2002","article-title":"Reversible memory loss in a mouse transgenic model of Alzheimer's disease","volume":"22","author":"Kotilinek","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0690","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1126\/science.1112125","article-title":"Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging","volume":"309","author":"Kujoth","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0695","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s11307-009-0198-z","article-title":"Limitations of small animal PET imaging with [18F]FDDNP and FDG for quantitative studies in a transgenic mouse model of Alzheimer's disease","volume":"11","author":"Kuntner","year":"2009","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0700","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0969-9961(03)00084-6","article-title":"Hyperphosphorylated tau and paired helical filament-like structures in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes","volume":"14","author":"Kurt","year":"2003","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0705","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1006\/exnr.2001.7717","article-title":"Neurodegenerative changes associated with beta-amyloid deposition in the brains of mice carrying mutant amyloid precursor protein and mutant presenilin-1 transgenes","volume":"171","author":"Kurt","year":"2001","journal-title":"Exp Neurol"},{"issue":"203","key":"10.1016\/j.pharmthera.2013.12.009_bb0710","first-page":"e201","article-title":"Early temporal short-term memory deficits in double transgenic APP\/PS1 mice","volume":"33","author":"Lagadec","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0715","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0006-8993(02)03476-5","article-title":"Spatial learning, exploration, anxiety, and motor coordination in female APP23 transgenic mice with the Swedish mutation","volume":"956","author":"Lalonde","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0725","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.neurobiolaging.2004.01.005","article-title":"The lipophilic metal chelator DP-109 reduces amyloid pathology in brains of human beta-amyloid precursor protein transgenic mice","volume":"25","author":"Lee","year":"2004","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0740","doi-asserted-by":"crossref","first-page":"5953","DOI":"10.1523\/JNEUROSCI.0465-12.2012","article-title":"Impaired short-term plasticity in mossy fiber synapses caused by mitochondrial dysfunction of dentate granule cells is the earliest synaptic deficit in a mouse model of Alzheimer's disease","volume":"32","author":"Lee","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0730","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1111\/j.1471-4159.2008.05769.x","article-title":"Behavioral stress accelerates plaque pathogenesis in the brain of Tg2576 mice via generation of metabolic oxidative stress","volume":"108","author":"Lee","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0720","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.neurobiolaging.2010.03.024","article-title":"Human umbilical cord blood-derived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimer's disease mouse model through modulation of neuroinflammation","volume":"33","author":"Lee","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0735","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3233\/JAD-2011-111025","article-title":"Dietary supplementation with S-adenosyl methionine delayed amyloid-beta and tau pathology in 3xTg-AD mice","volume":"28","author":"Lee","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0745","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.ajpath.2012.08.012","article-title":"Lack of tau proteins rescues neuronal cell death and decreases amyloidogenic processing of APP in APP\/PS1 mice","volume":"181","author":"Leroy","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0750","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nature04533","article-title":"A specific amyloid-beta protein assembly in the brain impairs memory","volume":"440","author":"Lesne","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0765","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/ng1295-376","article-title":"Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase","volume":"11","author":"Li","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0755","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/biof.5520320120","article-title":"Diet supplement CoQ10 delays brain atrophy in aged transgenic mice with mutations in the amyloid precursor protein: an in vivo volume MRI study","volume":"32","author":"Li","year":"2008","journal-title":"Biofactors"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0760","doi-asserted-by":"crossref","first-page":"12483","DOI":"10.1523\/JNEUROSCI.2417-11.2011","article-title":"Neuronal production of transthyretin in human and murine Alzheimer's disease: is it protective?","volume":"31","author":"Li","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0770","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1523\/JNEUROSCI.4225-04.2005","article-title":"A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model","volume":"25","author":"Lim","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0775","doi-asserted-by":"crossref","first-page":"8370","DOI":"10.1523\/JNEUROSCI.21-21-08370.2001","article-title":"The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse","volume":"21","author":"Lim","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0780","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0197-4580(01)00299-8","article-title":"Ibuprofen effects on Alzheimer pathology and open field activity in APPsw transgenic mice","volume":"22","author":"Lim","year":"2001","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0785","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.bbr.2010.12.030","article-title":"Treadmill exercise prevents decline in spatial learning and memory in APP\/PS1 transgenic mice through improvement of hippocampal long-term potentiation","volume":"218","author":"Liu","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0790","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.neurobiolaging.2010.08.005","article-title":"Characterization of 7- and 19-month-old Tg2576 mice using multimodal in vivo imaging: limitations as a translatable model of Alzheimer's disease","volume":"33","author":"Luo","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0795","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0006-8993(03)02658-1","article-title":"Degeneration of beta-amyloid-associated cholinergic structures in transgenic APP SW mice","volume":"977","author":"Luth","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0800","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.exger.2011.02.006","article-title":"Age-related autophagy alterations in the brain of senescence accelerated mouse prone 8 (SAMP8) mice","volume":"46","author":"Ma","year":"2011","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0805","doi-asserted-by":"crossref","first-page":"9078","DOI":"10.1523\/JNEUROSCI.1071-09.2009","article-title":"Beta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcumin","volume":"29","author":"Ma","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0810","doi-asserted-by":"crossref","first-page":"e25416","DOI":"10.1371\/journal.pone.0025416","article-title":"Inducing autophagy by rapamycin before, but not after, the formation of plaques and tangles ameliorates cognitive deficits","volume":"6","author":"Majumder","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0815","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1523\/JNEUROSCI.0059-07.2007","article-title":"Pyrrolidine dithiocarbamate activates Akt and improves spatial learning in APP\/PS1 mice without affecting beta-amyloid burden","volume":"27","author":"Malm","year":"2007","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0820","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11357-011-9343-0","article-title":"Age-related loss of noradrenergic neurons in the brains of triple transgenic mice","volume":"35","author":"Manaye","year":"2013","journal-title":"Age (Dordr)"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0825","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1006\/neur.1996.0057","article-title":"Pyramidal nerve cell loss in Alzheimer's disease","volume":"5","author":"Mann","year":"1996","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0830","doi-asserted-by":"crossref","first-page":"e31310","DOI":"10.1371\/journal.pone.0031310","article-title":"Small-animal PET imaging of amyloid-beta plaques with [11C]PiB and its multi-modal validation in an APP\/PS1 mouse model of Alzheimer's disease","volume":"7","author":"Manook","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0835","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1093\/cercor\/bhr216","article-title":"IRS-2 deficiency impairs NMDA receptor-dependent long-term potentiation","volume":"22","author":"Martin","year":"2012","journal-title":"Cereb Cortex"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0840","doi-asserted-by":"crossref","first-page":"870","DOI":"10.2353\/ajpath.2010.090452","article-title":"Memantine improves cognition and reduces Alzheimer's-like neuropathology in transgenic mice","volume":"176","author":"Martinez-Coria","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0845","doi-asserted-by":"crossref","first-page":"12506","DOI":"10.1073\/pnas.0705346104","article-title":"Modulation of human neural stem cell differentiation in Alzheimer (APP23) transgenic mice by phenserine","volume":"104","author":"Marutle","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0850","doi-asserted-by":"crossref","first-page":"13576","DOI":"10.1073\/pnas.0902714106","article-title":"Overexpression of SOD-2 reduces hippocampal superoxide and prevents memory deficits in a mouse model of Alzheimer's disease","volume":"106","author":"Massaad","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0855","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1471-2202-9-81","article-title":"Detailed immunohistochemical characterization of temporal and spatial progression of Alzheimer's disease-related pathologies in male triple-transgenic mice","volume":"9","author":"Mastrangelo","year":"2008","journal-title":"BMC Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0860","doi-asserted-by":"crossref","first-page":"16507","DOI":"10.1523\/JNEUROSCI.3647-11.2011","article-title":"Robust central reduction of amyloid-beta in humans with an orally available, non-peptidic beta-secretase inhibitor","volume":"31","author":"May","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0865","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S0197-4580(01)00344-X","article-title":"Age-related disruptions in circadian timing: evidence for \u201csplit\u201d activity rhythms in the SAMP8","volume":"23","author":"McAuley","year":"2002","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0870","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0197-4580(99)00018-4","article-title":"Age-related cochlear hair cell loss is enhanced in mice lacking copper\/zinc superoxide dismutase","volume":"20","author":"McFadden","year":"1999","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0875","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neuron.2005.06.030","article-title":"Abeta42 is essential for parenchymal and vascular amyloid deposition in mice","volume":"47","author":"McGowan","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0880","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.brainres.2008.01.095","article-title":"Ibuprofen reduces Abeta, hyperphosphorylated tau and memory deficits in Alzheimer mice","volume":"1207","author":"McKee","year":"2008","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0885","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/00007691-199312000-00027","article-title":"Desferrioxamine and Alzheimer's disease: video home behavior assessment of clinical course and measures of brain aluminum","volume":"15","author":"McLachlan","year":"1993","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0890","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s12975-010-0027-3","article-title":"Manganese superoxide dismutase deficiency exacerbates ischemic brain damage under hyperglycemic conditions by altering autophagy","volume":"2","author":"Mehta","year":"2011","journal-title":"Transl Stroke Res"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0895","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1089\/ars.2011.4037","article-title":"Oxidative stress, inflammation, and autophagic stress as the key mechanisms of premature age-related hearing loss in SAMP8 mouse cochlea","volume":"16","author":"Menardo","year":"2012","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0900","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nature06616","article-title":"Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer's disease","volume":"451","author":"Meyer-Luehmann","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0905","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1345\/aph.1Q238","article-title":"Rosiglitazone and pioglitazone for the treatment of Alzheimer's disease","volume":"45","author":"Miller","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0910","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1124\/jpet.104.071027","article-title":"Memantine improves spatial learning in a transgenic mouse model of Alzheimer's disease","volume":"311","author":"Minkeviciene","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0915","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1016\/j.neurobiolaging.2013.04.010","article-title":"Altered synapses and gliotransmission in Alzheimer's disease and AD model mice","volume":"34","author":"Mitew","year":"2013","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0920","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1023\/B:NEUR.0000044197.83514.64","article-title":"Dendrite and dendritic spine alterations in Alzheimer models","volume":"33","author":"Moolman","year":"2004","journal-title":"J Neurocytol"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0925","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/sj.npp.1300668","article-title":"Ibuprofen suppresses interleukin-1beta induction of pro-amyloidogenic alpha1-antichymotrypsin to ameliorate beta-amyloid (Abeta) pathology in Alzheimer's models","volume":"30","author":"Morihara","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0930","doi-asserted-by":"crossref","first-page":"12920","DOI":"10.1073\/pnas.231472998","article-title":"Methionine sulfoxide reductase (MsrA) is a regulator of antioxidant defense and lifespan in mammals","volume":"98","author":"Moskovitz","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0935","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.neulet.2009.08.038","article-title":"Caloric restriction attenuates amyloid deposition in middle-aged dtg APP\/PS1 mice","volume":"464","author":"Mouton","year":"2009","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0940","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1523\/JNEUROSCI.20-11-04050.2000","article-title":"High-level neuronal expression of abeta 1\u201342 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation","volume":"20","author":"Mucke","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0945","doi-asserted-by":"crossref","first-page":"e67630","DOI":"10.1371\/journal.pone.0067630","article-title":"Diffusion tensor magnetic resonance imaging of the brain in APP transgenic mice: a cohort study","volume":"8","author":"Muller","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0950","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1046\/j.1471-4159.2003.01837.x","article-title":"Advanced glycation endproducts and pro-inflammatory cytokines in transgenic Tg2576 mice with amyloid plaque pathology","volume":"86","author":"Munch","year":"2003","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0955","doi-asserted-by":"crossref","first-page":"44557","DOI":"10.1074\/jbc.M111.279208","article-title":"SOD1 (copper\/zinc superoxide dismutase) deficiency drives amyloid beta protein oligomerization and memory loss in mouse model of Alzheimer disease","volume":"286","author":"Murakami","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0960","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0891-5849(97)00164-0","article-title":"Mitochondrial dysfunction in the senescence accelerated mouse (SAM)","volume":"24","author":"Nakahara","year":"1998","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0965","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1742-2094-5-13","article-title":"Exercise alters the immune profile in Tg2576 Alzheimer mice toward a response coincident with improved cognitive performance and decreased amyloid","volume":"5","author":"Nichol","year":"2008","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0970","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.brainres.2010.05.084","article-title":"Regional cerebral glucose uptake in the 3xTG model of Alzheimer's disease highlights common regional vulnerability across AD mouse models","volume":"1347","author":"Nicholson","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0975","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1749-6632.1996.tb39080.x","article-title":"Senescence-accelerated mouse. Neurochemical studies on aging","volume":"786","author":"Nomura","year":"1996","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0995","doi-asserted-by":"crossref","first-page":"10129","DOI":"10.1523\/JNEUROSCI.1202-06.2006","article-title":"Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: potential factors in amyloid plaque formation","volume":"26","author":"Oakley","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0980","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.neuron.2008.10.047","article-title":"Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis","volume":"60","author":"O'Connor","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1000","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.neuron.2004.07.003","article-title":"Abeta immunotherapy leads to clearance of early, but not late, hyperphosphorylated tau aggregates via the proteasome","volume":"43","author":"Oddo","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1005","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1471-4159.2007.04607.x","article-title":"Genetically augmenting tau levels does not modulate the onset or progression of Abeta pathology in transgenic mice","volume":"102","author":"Oddo","year":"2007","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1010","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.neurobiolaging.2003.08.012","article-title":"Amyloid deposition precedes tangle formation in a triple transgenic model of Alzheimer's disease","volume":"24","author":"Oddo","year":"2003","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1015","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","article-title":"Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction","volume":"39","author":"Oddo","year":"2003","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1020","doi-asserted-by":"crossref","first-page":"39413","DOI":"10.1074\/jbc.M608485200","article-title":"Reduction of soluble Abeta and tau, but not soluble Abeta alone, ameliorates cognitive decline in transgenic mice with plaques and tangles","volume":"281","author":"Oddo","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1025","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1016\/j.mad.2005.07.006","article-title":"Amyloid peptide attenuates the proteasome activity in neuronal cells","volume":"126","author":"Oh","year":"2005","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1030","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1460-9568.2005.04551.x","article-title":"Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1","volume":"23","author":"Ohno","year":"2006","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1035","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.nbd.2006.12.008","article-title":"BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP\/PS1 transgenic mice","volume":"26","author":"Ohno","year":"2007","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0896-6273(03)00810-9","article-title":"BACE1 deficiency rescues memory deficits and cholinergic dysfunction in a mouse model of Alzheimer's disease","volume":"41","author":"Ohno","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1045","doi-asserted-by":"crossref","first-page":"9619","DOI":"10.1073\/pnas.0600966103","article-title":"Nonviral Abeta DNA vaccine therapy against Alzheimer's disease: long-term effects and safety","volume":"103","author":"Okura","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0985","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jchemneu.2007.05.008","article-title":"Catecholaminergic neuronal loss in locus coeruleus of aged female dtg APP\/PS1 mice","volume":"34","author":"O'Neil","year":"2007","journal-title":"J Chem Neuroanat"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1050","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1474-9726.2006.00196.x","article-title":"Radioiodinated clioquinol as a biomarker for beta-amyloid: Zn complexes in Alzheimer's disease","volume":"5","author":"Opazo","year":"2006","journal-title":"Aging Cell"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0990","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s11481-011-9282-7","article-title":"Rosiglitazone improves spatial memory and decreases insoluble Abeta(1\u201342) in APP\/PS1 mice","volume":"7","author":"O'Reilly","year":"2012","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1055","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.nbd.2007.12.008","article-title":"Short-term exercise in aged Tg2576 mice alters neuroinflammation and improves cognition","volume":"30","author":"Parachikova","year":"2008","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1060","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1083\/jcb.201010024","article-title":"Mitochondrial DNA mutations in disease and aging","volume":"193","author":"Park","year":"2011","journal-title":"J Cell Biol"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1065","doi-asserted-by":"crossref","first-page":"5063","DOI":"10.1073\/pnas.1015413108","article-title":"Scavenger receptor CD36 is essential for the cerebrovascular oxidative stress and neurovascular dysfunction induced by amyloid-beta","volume":"108","author":"Park","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1070","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/BF03325217","article-title":"A randomized controlled study on effects of ibuprofen on cognitive progression of Alzheimer's disease","volume":"21","author":"Pasqualetti","year":"2009","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1075","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006373","article-title":"Molecular mechanism for age-related memory loss: the histone-binding protein RbAp48","volume":"5","author":"Pavlopoulos","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1080","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.expneurol.2006.01.018","article-title":"Rosiglitazone attenuates learning and memory deficits in Tg2576 Alzheimer mice","volume":"199","author":"Pedersen","year":"2006","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1085","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.bbagen.2009.06.003","article-title":"Is the oxidative stress theory of aging dead?","volume":"1790","author":"Perez","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1090","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.neuroscience.2008.01.025","article-title":"Acquisition of conditioned taste aversion is impaired in the amyloid precursor protein\/presenilin 1 mouse model of Alzheimer's disease","volume":"152","author":"Pistell","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1095","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1016\/j.neurobiolaging.2011.12.024","article-title":"PET imaging with [18F]AV-45 in an APP\/PS1-21 murine model of amyloid plaque deposition","volume":"33","author":"Poisnel","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1100","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/j.neurobiolaging.2011.09.026","article-title":"Increased regional cerebral glucose uptake in an APP\/PS1 model of Alzheimer's disease","volume":"33","author":"Poisnel","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1105","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neuroscience.2008.05.023","article-title":"Subfield and layer-specific depletion in calbindin-D28K, calretinin and parvalbumin immunoreactivity in the dentate gyrus of amyloid precursor protein\/presenilin 1 transgenic mice","volume":"155","author":"Popovic","year":"2008","journal-title":"Neuroscience"},{"issue":"63\u201375","key":"10.1016\/j.pharmthera.2013.12.009_bb1110","first-page":"e62","article-title":"The global prevalence of dementia: a systematic review and metaanalysis","volume":"9","author":"Prince","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1115","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bbr.2006.11.044","article-title":"Non-cognitive behaviours in an APP\/PS1 transgenic model of Alzheimer's disease","volume":"178","author":"Pugh","year":"2007","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1120","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.2010.1510","article-title":"Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial","volume":"304","author":"Quinn","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1125","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1038\/sj.embor.7400784","article-title":"Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology","volume":"7","author":"Radde","year":"2006","journal-title":"EMBO Rep"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1130","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1007\/s007020070011","article-title":"No evidence for cognitive improvement from oral nicotinamide adenine dinucleotide (NADH) in dementia","volume":"107","author":"Rainer","year":"2000","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1135","first-page":"9","article-title":"Behavioral symptoms in Alzheimer's disease: phenomenology and treatment","volume":"48","author":"Reisberg","year":"1987","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1140","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/1533317508325094","article-title":"Efficacy of a vitamin\/nutriceutical formulation for moderate-stage to later-stage Alzheimer's disease: a placebo-controlled pilot study","volume":"24","author":"Remington","year":"2009","journal-title":"Am J Alzheimers Dis Other Demen"},{"issue":"426","key":"10.1016\/j.pharmthera.2013.12.009_bb1145","doi-asserted-by":"crossref","first-page":"426.e1","DOI":"10.1016\/j.neurobiolaging.2010.10.009","article-title":"Locus coeruleus degeneration exacerbates olfactory deficits in APP\/PS1 transgenic mice","volume":"33","author":"Rey","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1150","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1519\/JPT.0b013e31820aab9c","article-title":"A randomized controlled trial of an activity specific exercise program for individuals with Alzheimer disease in long-term care settings","volume":"34","author":"Roach","year":"2011","journal-title":"J Geriatr Phys Ther"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1155","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1440-1819.2007.01729.x","article-title":"Risperidone, olanzapine and quetiapine in the treatment of behavioral and psychological symptoms in patients with Alzheimer's disease: preliminary findings from a naturalistic, retrospective study","volume":"61","author":"Rocca","year":"2007","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1160","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1523\/JNEUROSCI.5620-07.2008","article-title":"Lack of pathology in a triple transgenic mouse model of Alzheimer's disease after overexpression of the anti-apoptotic protein Bcl-2","volume":"28","author":"Rohn","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1165","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/nrd3802","article-title":"Autophagy modulation as a potential therapeutic target for diverse diseases","volume":"11","author":"Rubinsztein","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1170","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/jnen\/63.5.418","article-title":"Amyloid-beta deposition is associated with decreased hippocampal glucose metabolism and spatial memory impairment in APP\/PS1 mice","volume":"63","author":"Sadowski","year":"2004","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1175","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1111\/j.1474-9726.2011.00709.x","article-title":"Role of superoxide-nitric oxide interactions in the accelerated age-related loss of muscle mass in mice lacking Cu, Zn superoxide dismutase","volume":"10","author":"Sakellariou","year":"2011","journal-title":"Aging Cell"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1180","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1096\/fj.08-127415","article-title":"Lack of methionine sulfoxide reductase A in mice increases sensitivity to oxidative stress but does not diminish life span","volume":"23","author":"Salmon","year":"2009","journal-title":"FASEB J"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1190","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1016\/j.neurobiolaging.2009.10.009","article-title":"Efficacy of PPAR-gamma agonist pioglitazone in mild Alzheimer disease","volume":"32","author":"Sato","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1185","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0047-6374(95)01681-3","article-title":"Early and transient increase in oxidative stress in the cerebral cortex of senescence-accelerated mouse","volume":"86","author":"Sato","year":"1996","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1195","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1126\/science.1106653","article-title":"Extension of murine life span by overexpression of catalase targeted to mitochondria","volume":"308","author":"Schriner","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1200","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.neuropharm.2010.09.002","article-title":"Chronic treatment with the alpha2-adrenoceptor antagonist fluparoxan prevents age-related deficits in spatial working memory in APPxPS1 transgenic mice without altering beta-amyloid plaque load or astrocytosis","volume":"60","author":"Scullion","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1205","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.neurobiolaging.2003.12.008","article-title":"Species-specific immune response to immunization with human versus rodent A beta peptide","volume":"25","author":"Seabrook","year":"2004","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1210","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.neurobiolaging.2006.04.007","article-title":"Dendrimeric Abeta1-15 is an effective immunogen in wildtype and APP-tg mice","volume":"28","author":"Seabrook","year":"2007","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1215","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1073\/pnas.1112209109","article-title":"Withania somnifera reverses Alzheimer's disease pathology by enhancing low-density lipoprotein receptor-related protein in liver","volume":"109","author":"Sehgal","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1220","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.mad.2010.06.004","article-title":"Spatial memory is enhanced in long-living Ames dwarf mice and maintained following kainic acid induced neurodegeneration","volume":"131","author":"Sharma","year":"2010","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1225","doi-asserted-by":"crossref","first-page":"6159","DOI":"10.1021\/pr201169q","article-title":"Longitudinal characterization of the brain proteomes for the tg2576 amyloid mouse model using shotgun based mass spectrometry","volume":"11","author":"Shevchenko","year":"2012","journal-title":"J Proteome Res"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1230","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1016\/S0002-9440(10)61173-X","article-title":"Life span extension by reduction in growth hormone-insulin-like growth factor-1 axis in a transgenic rat model","volume":"160","author":"Shimokawa","year":"2002","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1235","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.expneurol.2009.05.032","article-title":"Molecular imaging of neurodegeneration by a novel cross-disease biomarker","volume":"219","author":"Shirvan","year":"2009","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1240","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.2967\/jnumed.112.110163","article-title":"Longitudinal amyloid imaging in mouse brain with 11C-PIB: comparison of APP23, Tg2576, and APPswe-PS1dE9 mouse models of Alzheimer disease","volume":"54","author":"Snellman","year":"2013","journal-title":"J Nucl Med"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1245","doi-asserted-by":"crossref","first-page":"8082","DOI":"10.1523\/JNEUROSCI.21-20-08082.2001","article-title":"Late-onset corticohippocampal neurodepletion attributable to catastrophic failure of oxidative phosphorylation in MILON mice","volume":"21","author":"Sorensen","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1250","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/S0014-4886(03)00399-6","article-title":"Prevention of age-related spatial memory deficits in a transgenic mouse model of Alzheimer's disease by chronic Ginkgo biloba treatment","volume":"184","author":"Stackman","year":"2003","journal-title":"Exp Neurol"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1255","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.1523\/JNEUROSCI.0462-04.2004","article-title":"Cortical synaptic integration in vivo is disrupted by amyloid-beta plaques","volume":"24","author":"Stern","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1260","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.brainres.2010.06.011","article-title":"Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 2. Behavioral and cognitive changes","volume":"1348","author":"Sterniczuk","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1265","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.brainres.2010.05.013","article-title":"Characterization of the 3xTg-AD mouse model of Alzheimer's disease: part 1. Circadian changes","volume":"1348","author":"Sterniczuk","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1270","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1212\/01.WNL.0000160089.43264.1A","article-title":"MRI predictors of risk of incident Alzheimer disease: a longitudinal study","volume":"64","author":"Stoub","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1275","doi-asserted-by":"crossref","first-page":"8098","DOI":"10.1073\/pnas.90.17.8098","article-title":"Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1280","doi-asserted-by":"crossref","first-page":"13287","DOI":"10.1073\/pnas.94.24.13287","article-title":"Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology","volume":"94","author":"Sturchler-Pierrat","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1285","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1749-6632.2000.tb06915.x","article-title":"Pathogenic mechanisms of Alzheimer's disease analyzed in the APP23 transgenic mouse model","volume":"920","author":"Sturchler-Pierrat","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1290","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.neuron.2008.10.001","article-title":"Cystatin C-cathepsin B axis regulates amyloid beta levels and associated neuronal deficits in an animal model of Alzheimer's disease","volume":"60","author":"Sun","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1295","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1677\/joe.1.06631","article-title":"Endocrine, liver-derived IGF-I is of importance for spatial learning and memory in old mice","volume":"189","author":"Svensson","year":"2006","journal-title":"J Endocrinol"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1300","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1016\/j.ajpath.2011.02.012","article-title":"Inflammation induced by infection potentiates tau pathological features in transgenic mice","volume":"178","author":"Sy","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1305","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1073\/pnas.0408235102","article-title":"Changes in extracellular space size and geometry in APP23 transgenic mice: a model of Alzheimer's disease","volume":"102","author":"Sykova","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1310","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neulet.2009.07.055","article-title":"Age-dependent changes in noradrenergic locus coeruleus system in wild-type and APP23 transgenic mice","volume":"463","author":"Szot","year":"2009","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1315","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1126\/science.1142179","article-title":"Brain IRS2 signaling coordinates life span and nutrient homeostasis","volume":"317","author":"Taguchi","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1320","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00429-010-0242-4","article-title":"Hippocampal interneuron loss in an APP\/PS1 double mutant mouse and in Alzheimer's disease","volume":"214","author":"Takahashi","year":"2010","journal-title":"Brain Struct Funct"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1325","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0047-6374(81)90084-1","article-title":"A new murine model of accelerated senescence","volume":"17","author":"Takeda","year":"1981","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1330","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1756-6606-1-21","article-title":"Normal mitochondrial respiratory function is essential for spatial remote memory in mice","volume":"1","author":"Tanaka","year":"2008","journal-title":"Mol Brain"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1335","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1073\/pnas.0813404106","article-title":"Intracerebroventricular amyloid-beta antibodies reduce cerebral amyloid angiopathy and associated micro-hemorrhages in aged Tg2576 mice","volume":"106","author":"Thakker","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1340","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0022-510X(81)90031-9","article-title":"Cell loss in the locus coeruleus in senile dementia of Alzheimer type","volume":"49","author":"Tomlinson","year":"1981","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1345","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1750-1326-7-59","article-title":"Defective lysosomal proteolysis and axonal transport are early pathogenic events that worsen with age leading to increased APP metabolism and synaptic Abeta in transgenic APP\/PS1 hippocampus","volume":"7","author":"Torres","year":"2012","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1350","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/nm1781","article-title":"Blocking TGF-beta-Smad2\/3 innate immune signaling mitigates Alzheimer-like pathology","volume":"14","author":"Town","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1355","doi-asserted-by":"crossref","first-page":"9513","DOI":"10.1523\/JNEUROSCI.0858-11.2011","article-title":"Controlled cortical impact traumatic brain injury in 3xTg-AD mice causes acute intra-axonal amyloid-beta accumulation and independently accelerates the development of tau abnormalities","volume":"31","author":"Tran","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1360","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/sj.mp.4002076","article-title":"Central actions of liver-derived insulin-like growth factor I underlying its pro-cognitive effects","volume":"12","author":"Trejo","year":"2007","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1365","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nature02517","article-title":"Premature ageing in mice expressing defective mitochondrial DNA polymerase","volume":"429","author":"Trifunovic","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1370","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1172\/JCI34254","article-title":"Inhibition of calpains improves memory and synaptic transmission in a mouse model of Alzheimer disease","volume":"118","author":"Trinchese","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1375","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1002\/ana.20101","article-title":"Progressive age-related development of Alzheimer-like pathology in APP\/PS1 mice","volume":"55","author":"Trinchese","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1380","doi-asserted-by":"crossref","first-page":"e32737","DOI":"10.1371\/journal.pone.0032737","article-title":"Defects in mitochondrial dynamics and metabolomic signatures of evolving energetic stress in mouse models of familial Alzheimer's disease","volume":"7","author":"Trushina","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1385","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/j.neurobiolaging.2007.04.014","article-title":"Abeta inhibits the proteasome and enhances amyloid and tau accumulation","volume":"29","author":"Tseng","year":"2008","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1390","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3233\/JAD-2010-100939","article-title":"A multi-center randomized proof-of-concept clinical trial applying [(1)(8)F]FDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimer's disease","volume":"22","author":"Tzimopoulou","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1395","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1124\/jpet.105.098566","article-title":"Effect of subchronic treatment of memantine, galantamine, and nicotine in the brain of Tg2576 (APPswe) transgenic mice","volume":"317","author":"Unger","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1400","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/ptr.3183","article-title":"Icariin improves memory impairment in Alzheimer's disease model mice (5xFAD) and attenuates amyloid beta-induced neurite atrophy","volume":"24","author":"Urano","year":"2010","journal-title":"Phytother Res"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1405","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1523\/JNEUROSCI.22-02-00446.2002","article-title":"Repetitive mild brain trauma accelerates Abeta deposition, lipid peroxidation, and cognitive impairment in a transgenic mouse model of Alzheimer amyloidosis","volume":"22","author":"Uryu","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1410","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00213-004-2132-z","article-title":"Symptomatic effect of donepezil, rivastigmine, galantamine and memantine on cognitive deficits in the APP23 model","volume":"180","author":"Van Dam","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1415","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/j.1476-5381.2011.01299.x","article-title":"Animal models in the drug discovery pipeline for Alzheimer's disease","volume":"164","author":"Van Dam","year":"2011","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1420","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.neuint.2004.11.005","article-title":"Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models","volume":"46","author":"Van Dam","year":"2005","journal-title":"Neurochem Int"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1425","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.bbr.2008.02.014","article-title":"Evaluation of the APP23-model for Alzheimer's disease in the odour paired-associate test for hippocampus-dependent memory","volume":"190","author":"Van Dijck","year":"2008","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1430","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1152\/physiolgenomics.00122.2003","article-title":"Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging","volume":"16","author":"Van Remmen","year":"2003","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1435","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1006\/abbi.1998.1060","article-title":"Characterization of the antioxidant status of the heterozygous manganese superoxide dismutase knockout mouse","volume":"363","author":"Van Remmen","year":"1999","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1440","doi-asserted-by":"crossref","first-page":"144","DOI":"10.2174\/156720509787602852","article-title":"Long-term follow-up of patients immunized with AN1792: reduced functional decline in antibody responders","volume":"6","author":"Vellas","year":"2009","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1445","first-page":"265","article-title":"Validation of the APP23 transgenic mouse model of Alzheimer's disease through evaluation of risperidone treatment on aggressive behaviour","volume":"58","author":"Vloeberghs","year":"2008","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1450","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1037\/0735-7044.120.6.1380","article-title":"Aggressive male APP23 mice modeling behavioral alterations in dementia","volume":"120","author":"Vloeberghs","year":"2006","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1455","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.neulet.2006.07.060","article-title":"APP23 mice display working memory impairment in the plus-shaped water maze","volume":"407","author":"Vloeberghs","year":"2006","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1460","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1111\/j.1460-9568.2004.03755.x","article-title":"Altered circadian locomotor activity in APP23 mice: a model for BPSD disturbances","volume":"20","author":"Vloeberghs","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1465","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.2741\/1370","article-title":"Cognitive function and its neural mechanisms in nonhuman primate models of aging, Alzheimer disease, and menopause","volume":"9","author":"Voytko","year":"2004","journal-title":"Front Biosci"},{"issue":"2109","key":"10.1016\/j.pharmthera.2013.12.009_bb1470","first-page":"e2115","article-title":"A genome-wide association study of aging","volume":"32","author":"Walter","year":"2011","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1475","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.neulet.2009.03.030","article-title":"Age-related spatial cognitive impairment is correlated with a decrease in ChAT in the cerebral cortex, hippocampus and forebrain of SAMP8 mice","volume":"454","author":"Wang","year":"2009","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1480","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.nbd.2003.08.009","article-title":"Gender differences in the amount and deposition of amyloidbeta in APPswe and PS1 double transgenic mice","volume":"14","author":"Wang","year":"2003","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1485","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neulet.2012.12.041","article-title":"Facilitation of memory impairment and cholinergic disturbance in a mouse model of Alzheimer's disease by mild ischemic burden","volume":"536","author":"Watanabe","year":"2013","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1490","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1750-3639.2008.00166.x","article-title":"Transthyretin accelerates vascular Abeta deposition in a mouse model of Alzheimer's disease","volume":"19","author":"Wati","year":"2009","journal-title":"Brain Pathol"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1495","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0197-4580(00)00181-0","article-title":"The role of microglial cells and astrocytes in fibrillar plaque evolution in transgenic APP(SW) mice","volume":"22","author":"Wegiel","year":"2001","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1500","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.neuroscience.2004.01.050","article-title":"The presence of the APP(swe) mutation in mice does not increase the vulnerability of cholinergic basal forebrain neurons to neuroinflammation","volume":"125","author":"Wenk","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1505","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1523\/JNEUROSCI.22-05-01858.2002","article-title":"The relationship between Abeta and memory in the Tg2576 mouse model of Alzheimer's disease","volume":"22","author":"Westerman","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1510","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/ana.410100203","article-title":"Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis","volume":"10","author":"Whitehouse","year":"1981","journal-title":"Ann Neurol"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1515","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1523\/JNEUROSCI.23-09-03745.2003","article-title":"Intracranially administered anti-Abeta antibodies reduce beta-amyloid deposition by mechanisms both independent of and associated with microglial activation","volume":"23","author":"Wilcock","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1520","doi-asserted-by":"crossref","first-page":"6144","DOI":"10.1523\/JNEUROSCI.1090-04.2004","article-title":"Passive amyloid immunotherapy clears amyloid and transiently activates microglia in a transgenic mouse model of amyloid deposition","volume":"24","author":"Wilcock","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1525","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3233\/JAD-2011-111616","article-title":"Memantine and brain atrophy in Alzheimer's disease: a 1-year randomized controlled trial","volume":"29","author":"Wilkinson","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1530","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1474-4422(12)70140-0","article-title":"Safety, tolerability, and antibody response of active Abeta immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study","volume":"11","author":"Winblad","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1535","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1007\/s00401-006-0041-4","article-title":"Axonopathy in an APP\/PS1 transgenic mouse model of Alzheimer's disease","volume":"111","author":"Wirths","year":"2006","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1540","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.neuroscience.2004.11.018","article-title":"Sleep and circadian abnormalities in a transgenic mouse model of Alzheimer's disease: a role for cholinergic transmission","volume":"131","author":"Wisor","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1545","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.biopsych.2006.04.004","article-title":"Cognitive and physical activity differently modulate disease progression in the amyloid precursor protein (APP)-23 model of Alzheimer's disease","volume":"60","author":"Wolf","year":"2006","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1550","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.neurobiolaging.2007.09.003","article-title":"Dystrophic neurites in TgCRND8 and Tg2576 mice mimic human pathological brain aging","volume":"30","author":"Woodhouse","year":"2009","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb0575","series-title":"Dementia: a public health priority","author":"World Health Organization and Alzheimer\u2019s Disease International","year":"2012"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1555","doi-asserted-by":"crossref","first-page":"e59586","DOI":"10.1371\/journal.pone.0059586","article-title":"Neuroinflammation and neuronal loss precede Abeta plaque deposition in the hAPP-J20 mouse model of Alzheimer's disease","volume":"8","author":"Wright","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1560","doi-asserted-by":"crossref","first-page":"10706","DOI":"10.1523\/JNEUROSCI.2637-09.2009","article-title":"Characterizing the appearance and growth of amyloid plaques in APP\/PS1 mice","volume":"29","author":"Yan","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1565","doi-asserted-by":"crossref","first-page":"7504","DOI":"10.1523\/JNEUROSCI.23-20-07504.2003","article-title":"Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease","volume":"23","author":"Yan","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1570","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0006-8993(99)02207-6","article-title":"Plaque-associated alpha-synuclein (NACP) pathology in aged transgenic mice expressing amyloid precursor protein","volume":"853","author":"Yang","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1575","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.biopsych.2010.04.010","article-title":"Amelioration of the Alzheimer's disease phenotype by absence of 12\/15-lipoxygenase","volume":"68","author":"Yang","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1580","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1146\/annurev.pathmechdis.2.010506.092044","article-title":"The aging brain","volume":"3","author":"Yankner","year":"2008","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1585","doi-asserted-by":"crossref","first-page":"6041","DOI":"10.1523\/JNEUROSCI.22-14-06041.2002","article-title":"Myelination is altered in insulin-like growth factor-I null mutant mice","volume":"22","author":"Ye","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1590","doi-asserted-by":"crossref","first-page":"19198","DOI":"10.1073\/pnas.0505203102","article-title":"Brain estrogen deficiency accelerates Abeta plaque formation in an Alzheimer's disease animal model","volume":"102","author":"Yue","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1595","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jalz.2010.01.013","article-title":"Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline","volume":"6","author":"Yurko-Mauro","year":"2010","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.pharmthera.2013.12.009_bb1600","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/039463201202500107","article-title":"APP\/PS1 transgenic mice treated with aluminum: an update of Alzheimer's disease model","volume":"25","author":"Zhang","year":"2012","journal-title":"Int J Immunopathol Pharmacol"}],"container-title":["Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725813002519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725813002519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,5]],"date-time":"2019-08-05T02:09:30Z","timestamp":1564970970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725813002519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":320,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0163725813002519"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2013.12.009","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic mouse models of brain ageing and Alzheimer's disease","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2013.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}